Among these, CUL7, ENO2, and MPP2 consistently appeared in all four screening analyses (Figure 1c), highlighting their importance as genetic targets for further investigation into COAD immune mechanisms (Figures 1d–i). This evidence concerns the gene CUL7 and colon adenocarcinoma.